Write your message
Volume 7, Issue 3 (May - June 2022)                   J Obstet Gynecol Cancer Res 2022, 7(3): 251-253 | Back to browse issues page

XML Print

Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Sheikhhasani S, Saffar H, Zamani N, Peydayesh M, Nikfar S, Mohseni M. Primitive Neuroectodermal Tumor of the Ovary: A Case Report. J Obstet Gynecol Cancer Res. 2022; 7 (3) :251-253
URL: http://jogcr.com/article-1-397-en.html
1- Department of Gynecology Oncology, Vali-e-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran
2- Anatomical and Clinical Pathology, Cancer Institute, Imam Khomeini Hospital Complex, Tehran University of Medical Sciences, Tehran, Iran
3- Department of Gynecology, School of Medicine, Pasteur Hospital, Bam University of Medical Sciences, Bam, Iran
4- Department of Obstetrics and Gynecology, School of Medicine, Taleghani Hospital, Arak University of Medical Sciences, Arak, Iran
5- Department of Gynecology Oncology, Vali-e-Asr Hospital, Tehran University of Medical Sciences, Tehran, Iran , monamohsenigyneco@gmail.com
Full-Text [PDF 314 kb]   (125 Downloads)     |   Abstract (HTML)  (597 Views)
Full-Text:   (108 Views)

A primitive neuroectodermal tumor (PNET), which can be detected in different sites in the female genital system, is scary and malignant. This tumor's most prevalent involvement site is the ovary, and the uterine corpus, respectively (1, 2).
This tumor was classified into two subgroups (peripheral and central PENT) according to clinical characteristics, immunohistochemical (IHC) profiles, and genetics (3). However, it has the same pathology features in different cases, its clinical manifestation broadly varied (4).
In addition, the standard clinical presentation, treat-ment protocol, and prognosis of PENT, because of its rarity, have not been clearly described yet (5). Hence, herein we reported a case of ovarian peripheral PNET that her histomorphology reports caused to her certain diagnoses at Imam Khomeini Hospital, affiliated to Tehran University of Medical Sciences, in 2020.


Case Report

A 16-year-old virgin girl with three months experience of amenorrhea followed by spotting presented at the Vali-e-Asr Hospital hospital. She had a history of surgery due to an inguinal and umbilical hernia when she was eight. Her lab tests showed an elevated serum CA125 concentration up to 432.7 U/mL and CA19-9 up to 82 U/mL. AFP, βhCG, and CA15-3 had normal concentrations.
Magnetic resonance imaging (MRI) showed bico-rnate uterine features and a septated vagina. A solid and complex cyst measured 42*58 mm was reported in the left ovary. The right ovary was normal, with a little amount of fluid in the pelvic cavity.
During the laparotomy, the ovaries were an elong-ated and striped feature, and the uterine was septated. An exophytic mass measuring 8 cm in the left ovary and a dermoid mass measuring 3 cm in the right ovary were found. Finally, bilateral cystectomy (due to large ovarian masses) and liver biopsy were conducted.
Cytology revealed atypical cells. Microscopic evalu-ation showed neoplastic tissue with small cells and a high proportion of nuclear-cytoplasmic with mild pleomorphism in nuclei and several mitotic activities mainly ordered in sheets with the occasional organoid design. Furthermore, MIC2 (CD99), NSE, Synapto-physin, and Vimentin were positive in IHC analysis (Figure 1).

Figure 1. Immunohistochemical staining results in the study case

Figure 1. Immunohistochemical staining results in the study case


According to the above histopathological findings, the diagnosis of peripheral PENT was made. Imme-diately, six cycles of chemotherapy with Vincristine, Doxorbosin, and Cyclophosphamide were initiated. Six months after the disease detection, the patient was alive without evidence of recurrence or metastasis.



PNETs are an uncommon and poor prognosis tumor, typically affecting young people, children, and adolescents with a median age of 25 years. However, seldom studies indicated PNET in postmenopausal women, too (6,9).
The early diagnosis of pPNET is so hard because of its non-specific presentation, sign, and para-clinic data. As mentioned, there are no clear and specific para-clinic data such as imaging findings and tumor markers for PNET; however, in some patients (similar to our study case), serum CA-125 elevated was reported (10).
The key point in pPNET diagnosis is pathology reports and IHC staining analysis for specific tumor markers, including CD99, vimentin, synaptophysin (11). Furthermore, reverse transcription-polymerase chain reaction (RT-PCR) or fluorescence in situ hybridization (FISH) can be helpful in unusual tumor sites or patients with unspecific pathology and IHC findings (12).
considering limited reported cases with ovarian PNET, the most prevalent clinical manifestation were abdominal pain, abdominal distension, and pelvic masses. Microscopic, IHC, and FISH data were the gold diagnostic method, and no confirmed therapy exists yet, and most treatment usages are empirical.
Considering different clinical presentation, and poor prognosis of PNET compared to other ovarian malignancies, to on-time diagnosis and treatment, the patient's histomorphology and immunohistochemical (IHC) profile assessment, particularly in younger women seems beneficial.








Funding Source



Conflicts of Interest

Authors declared no conflict of interests.

Systematic Review: Case Report | Subject: Gynecology Oncology
Received: 2021/10/15 | Accepted: 2021/11/12 | Published: 2022/01/12

1. Blattner JM, Gable P, Quigley MM, McHale MT. Primitive neuroectodermal tumor of the uterus. Gynecol Oncol. 2007;106:419-22. [DOI:10.1016/j.ygyno.2007.04.008] [PMID]
2. De Nola R, Di Naro E, Schonauer LM, Lucarelli G, Battaglia M, Fiore MG, et al. Clinical management of a unique case of PNET of the uterus during pregnancy, and review of the literature. Medicine (Baltimore). 2018;97:e9505. [DOI:10.1097/MD.0000000000009505] [PMID] [PMCID]
3. Xiao C, Zhao J, Guo P, et al. Clinical analysis of primary primitive neuroectodermal tumors in the female genital tract. Int J Gynecol Cancer. 2014;24(3):404-409. [DOI:10.1097/IGC.0000000000000082] [PMID]
4. Demirtas, E., Guven, S., Guven, E.S., Baykal, C., Ayhan, A., 2004. Two successful spontaneous pregnancies in a patient with a primary primitive neuroectodermal tumor of the ovary. Fertil. Steril. 81 (3), 679-681. [DOI:10.1016/j.fertnstert.2003.08.036] [PMID]
5. Chao X, Bi Y, Li L. Ovarian primary primitive neuroectodermal tumor: a review of cases at PUMCH and in the published literature. Orphanet J Rare Dis. 2019;14(1):147. [DOI:10.1186/s13023-019-1106-5] [PMID] [PMCID]
6. Morovic A, Damjanov I. Neuroectodermal ovarian tumors: A Brief Overview. Histol Histopathol. 2008; 23(6): 765-71.
7. Nili F, Sedighi Moghadam Pour A, Moradi Tabriz H, Sedighi Moghadam Pour P, Saffar H. Peripheral Primitive Neuroectodermal Tumor of the Ovary: The Report of Two Rare Cases. Iran J Pathol. 2018; 13(4): 467-470.
8. Dizon AM, Kilgore LC, Grindstaff A, Winkler M, Kimball KJ. High grade primitive neuroectodermal tumor of the uterus: A case report. Gynecol Oncol Case Rep. 2013;7:10-2. [DOI:10.1016/j.gynor.2013.10.002] [PMID] [PMCID]
9. Yakıştıran B, Taşkın S, Cansız Ersöz C, Ortaç F. Primitive neuroectodermal tumor of genital tract in hysterectomized patient: A case report. Turk J Obstet Gynecol. 2018;15(3):204-209. [DOI:10.4274/tjod.88714] [PMID] [PMCID]
10. Nili F, Sedighi Moghadam Pour A, Moradi Tabriz H, Sedighi Moghadam Pour P, Saffar H. Peripheral Primitive Neuroectodermal Tumor of the Ovary: The Report of Two Rare Cases. Iran J Pathol. 2018 Fall;13(4):467-470. Epub 2018 Sep 25.
11. Sen S, Kashyap S, Thanikachalam S, Betharia SM. Primary primitive neuroectodermal tumor of the orbit. J Pediatr Ophthalmol Strabismus. 2002;39:242-4. [DOI:10.3928/0191-3913-20020701-15] [PMID]
12. Boldorini R, Riboni F, Cristina S, Allegrini S, Valentini S, Muscara M, et al. Primary vulvar Ewing's sarcoma/primitive neuroectodermal tumor in a postmenopausal woman: a case report. Pathol Res Pract. 2010;206:476-9. [DOI:10.1016/j.prp.2009.07.006] [PMID]

Add your comments about this article : Your username or Email:

Send email to the article author

Rights and permissions
Creative Commons License Journal of Obstetrics, Gynecology and Cancer Research by Farname Inc is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. Based on a work at http://jogcr.com/.

© 2022 CC BY-NC 4.0 | Journal of Obstetrics, Gynecology and Cancer Research (JOGCR)

Designed & Developed by : Yektaweb | Piblisher: Farname Inc.